Prolonged Prophylaxis of Thromboembolic Disease in Patients with Colorectal Surgical Resections for Malignancy

Abstract

The aim of our pilot study was to examine the changes in inflammatory reaction, changes of coagulation parameters and inhibition of FXa in patients with new diagnosed colorectal cancer. During 30 days of observation prophylactic dose of dalteparin 5000 UI subcutaneously once daily was administrated.

Keywords

• colorectal cancer
• colorectal resection
• venous thromboembolism
• low-molecular-weight heparins